1. Home
  2. MCD vs LLY Comparison

MCD vs LLY Comparison

Compare MCD & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MCD

McDonald's Corporation

HOLD

Current Price

$266.93

Market Cap

204.6B

ML Signal

HOLD

Logo Eli Lilly and Company

LLY

Eli Lilly and Company

HOLD

Current Price

$1,190.03

Market Cap

979.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCD
LLY
Founded
1940
1876
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6B
979.6B
IPO Year
1997
2007

Fundamental Metrics

Financial Performance
Metric
MCD
LLY
Price
$266.93
$1,190.03
Analyst Decision
Buy
Strong Buy
Analyst Count
29
19
Target Price
$344.17
$1,218.84
AVG Volume (30 Days)
4.1M
2.1M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
2.56%
0.81%
EPS Growth
4.92
95.99
EPS
6.10
16.19
Revenue
$26,885,000,000.00
$65,179,000,000.00
Revenue This Year
$7.65
$27.15
Revenue Next Year
$6.00
$16.04
P/E Ratio
$43.95
$76.19
Revenue Growth
3.72
44.70
52 Week Low
$260.96
$712.05
52 Week High
$341.75
$1,292.65

Technical Indicators

Market Signals
Indicator
MCD
LLY
Relative Strength Index (RSI) 45.14 49.60
Support Level $263.73 $1,148.95
Resistance Level $278.54 $1,240.73
Average True Range (ATR) 4.43 36.35
MACD -0.17 0.06
Stochastic Oscillator 18.94 31.11

Price Performance

Historical Comparison
MCD
LLY

About MCD McDonald's Corporation

McDonald's is the world's largest restaurant brand, with nearly $139 billion in systemwide sales across more than 45,000 restaurants and over 100 markets. The quick-service chain built its early reputation on speed, consistency, and affordable hamburgers, and today its global menu spans burgers, chicken, breakfast, and beverages that have helped popularize American fast-food cuisine worldwide. The firm derives the bulk of its revenue from franchise royalties and rent (about 62%), with the remainder stemming from company-operated restaurants across three segments: the United States (39% of systemwide sales), international operated markets (35%), and international developmental/licensed markets (26%).

About LLY Eli Lilly and Company

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Share on Social Networks: